Insider Trading & Ownership - AVENUE THERAPEUTICS INC. (ATXI)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for AVENUE THERAPEUTICS INC.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-05
Sale
2024-11-07
7:12 pm
AVENUE THERAPEUTICS INC.ATXIKRANZLER JAY D
Director
61$2.24$137559
(Direct)
View
2024-09-27
Purchase
2024-10-01
4:15 pm
AVENUE THERAPEUTICS INC.ATXIKRANZLER JAY D
Director
500$2.4994$1,250620
(Direct)
View
2023-12-11
Sale
2023-12-13
4:02 pm
AVENUE THERAPEUTICS INC.ATXIDavidow Robert L
10% Owner
617,000$0.14029$86,560761,000
(Indirect
Direct)
View
2023-09-08
Purchase
2023-09-12
09:03 am
AVENUE THERAPEUTICS INC.ATXIROSENWALD LINDSAY A MD
Director
348,675$0.72$251,046354,318
(Direct)
View
2023-09-08
Purchase
2023-09-12
09:02 am
AVENUE THERAPEUTICS INC.ATXIFortress Biotech Inc.
10% Owner
418,410$0.72$301,2551,032,390
(Direct)
View
2022-10-11
Sale
2022-10-13
8:52 pm
AVENUE THERAPEUTICS INC.ATXIInvaGen Pharmaceuticals Inc.
10% Owner
388,888$7.714$2,999,8820
(Indirect
Direct)
View
2021-09-15
Sale
2021-09-15
4:03 pm
AVENUE THERAPEUTICS INC.ATXIVazzano Joseph Walter
Chief Financial Officer
7,160$1.62$11,59965,252
(Direct)
View
2021-05-06
Purchase
2021-05-07
08:02 am
AVENUE THERAPEUTICS INC.ATXIHerskowitz Neil
Director
2,500$3.99$9,975134,724
(Direct)
View
2020-08-20
Sale
2020-08-21
4:15 pm
AVENUE THERAPEUTICS INC.ATXIVazzano Joseph Walter
Chief Financial Officer
3,840$12.13$46,57957,412
(Direct)
View
2020-03-09
Purchase
2020-03-10
4:42 pm
AVENUE THERAPEUTICS INC.ATXIVazzano Joseph Walter
Chief Financial Officer
3,389$7.9615$26,98261,252
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-23
Option Award
2024-09-25
4:59 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC.ATXIROSENWALD LINDSAY A MD
Director
30,000$030,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:57 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC.ATXIHerskowitz Neil
Director
30,000$030,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:55 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC.ATXIOltmans Curtis Gale
Director
30,000$030,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:55 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIMacLean Alexandra
Chief Executive Officer
170,000$0170,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:54 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC.ATXIKRANZLER JAY D
Director
30,000$030,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:53 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIJin David
Interim PFO and COO
65,000$065,000
(Direct)
View
2024-09-23
Option Award
2024-09-25
4:53 pm
N/A
2034-09-23
AVENUE THERAPEUTICS INC.ATXICharles Faith L.
Director
30,000$030,000
(Direct)
View
2024-04-16
Option Award
2024-04-17
4:05 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIFortress Biotech Inc.
10% Owner
413,507$03,547,393
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:27 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIFortress Biotech Inc.
10% Owner
2,101,496$03,133,886
(Direct)
View

Ownership
2023-11-28
4:01 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIDavidow Robert L
10% Owner
0$01,926,800
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:10 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC.ATXICharles Faith L.
Director
100,000$0100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:09 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC.ATXIJin David
Interim PFO and COO
250,000$0250,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:08 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC.ATXIROSENWALD LINDSAY A MD
Director
100,000$0100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:08 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC.ATXIKRANZLER JAY D
Director
100,000$0100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:07 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC.ATXIOltmans Curtis Gale
Director
100,000$0100,000
(Direct)
View
2023-06-30
Option Award
2023-07-05
4:07 pm
N/A
2033-06-30
AVENUE THERAPEUTICS INC.ATXIHerskowitz Neil
Director
100,000$0100,000
(Direct)
View
2023-06-29
Option Award
2023-07-03
1:05 pm
N/A
2033-06-29
AVENUE THERAPEUTICS INC.ATXIMacLean Alexandra
Chief Executive Officer
800,000$0800,000
(Direct)
View
2023-03-31
Option Award
2023-04-04
4:08 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIFortress Biotech Inc.
10% Owner
52,419$0613,980
(Direct)
View
2022-12-31
Option Award
2023-01-04
5:49 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIFortress Biotech Inc.
10% Owner
322,225$0811,561
(Direct)
View
2021-12-17
Option Award
2021-12-21
4:26 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIKRANZLER JAY D
Director
69,020$0133,683
(Direct)
View
2021-12-17
Option Award
2021-12-21
4:26 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIHerskowitz Neil
Director
69,020$0183,744
(Direct)
View
2021-12-17
Option Award
2021-12-21
4:24 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIOltmans Curtis Gale
Director
49,020$049,020
(Direct)
View
2021-12-17
Option Award
2021-12-20
5:08 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXILu Lucy
President, CEO
411,616$0748,949
(Direct)
View
2021-12-17
Option Award
2021-12-20
5:07 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIVazzano Joseph Walter
Chief Financial Officer
100,505$0165,757
(Direct)
View
2020-06-16
Option Award
2020-06-16
5:09 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIKRANZLER JAY D
Director
10,000$084,663
(Direct)
View
2020-06-16
Option Award
2020-06-16
5:09 pm
N/A
N/A
AVENUE THERAPEUTICS INC.ATXIHerskowitz Neil
Director
10,000$0132,224
(Direct)
View
Goto 0, 1, Next